Results 161 to 170 of about 39,769 (244)

Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy. [PDF]

Biochem Biophys Rep
Cedervall T, Jude B, von Walden F, Velentza L, Lanner JT, Sejersen T, Zaman F, Sävendahl L.   +7 more
europepmc   +1 more source

Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone. [PDF]

J Endocr Soc
Sbrocchi AM, Kinnett K, Lautatzis ME, McMillan HJ, Selby KA, Veerapandiyan A, Weber DR, Apkon S, Bharucha-Goebel DX, Bharill S, Bansal S, Clemens PR, Fiscaletti M, Halloun R, Lam C, Merchant N, McAdam L, Nasomyont N, Nicolau S, Ochoa Molina MF, Phung K, Rutter MM, Scavina M, Surampudi PN, Tamaroff J, Tian C, Ward LM, Wood CL, Wong SC, Ahmet A, OPTIMIZE DMD Consortium .   +30 more
europepmc   +1 more source

Assessing Delays in Time to Diagnosis of Duchenne Muscular Dystrophy: A Survey of Current Primary Care Practices. [PDF]

Cureus
Veerapandiyan A, Hagan JF, Lipkin P, Duvuru R, Chahal J, Chahal JK, Glasner M.   +6 more
europepmc   +1 more source

The story of the progress reports on research into gene therapies for Duchenne muscular dystrophy.

, 2009
Reinhardt Rüdel
openalex   +1 more source

Proximity to Healthcare Services Among Individuals With Duchenne Muscular Dystrophy. [PDF]

AJPM Focus
Thomas S, Jaff TA, Conway KM, Romitti PA, Insaf TZ, Sommerhalter K, Gedlinske A, Crenshaw E, Whitehead N, Humphries B, Berry R, Royer J, Mann JR, Krikov S, Pula Jayaram MJ, Feldkamp ML, Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).   +18 more
europepmc   +1 more source

Upper limb function and quality of life in Duchenne muscular dystrophy: a cross-sectional study in Chile. [PDF]

Sci Rep
Avila-Smirnow D, Pérez C, Moscoso O, Lucero-González N.   +3 more
europepmc   +1 more source

Muscle Satellite Cells and Duchenne Muscular Dystrophy

, 2012
Yuko Miyagoe‐Suzuki, So‐ichiro Fukada, Shinichi Take   +2 more
openalex   +2 more sources

Fighting for every beat: cardiac therapies in Duchenne muscular dystrophy. [PDF]

Skelet Muscle
Muchir A.
europepmc   +1 more source

Pamrevlumab did not meet its primary endpoint for non-ambulatory patients with Duchenne Muscular Dystrophy: the LELANTOS-1 trial [PDF]

Anne M. Connolly, Brenda Wong, H. Phan, Eugenio Mercuri, Xiaotang Cai, Cuixia Tian, Silvana De Lucia, Stanley F. Nelson, Yann Péréon, Stefano C. Previtali, Steven Wang, Olga V. Gambetti, John F. Brandsema, Ewa Carrier   +13 more
openalex   +1 more source

Delandistrogene Moxeparvovec gene therapy for Duchenne muscular dystrophy: the way forward in South Asian countries. [PDF]

Lancet Reg Health Southeast Asia
Madaan P, Mishra SK, Wanigasinghe J, Sahu JK.   +3 more
europepmc   +1 more source